Aquaculture Healthcare Market to cross $1.25 billion by 2028, Says Global Market Insights Inc.
February 02, 2022 03:35 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Global aquaculture healthcare market revenue is projected to cross USD 1.25 billion by 2028, according to a new research report by Global...
Animal Drugs Market value to hit $41 billion by 2025: Global Market Insights, Inc.
December 01, 2019 20:00 ET
|
Global Market Insights, Inc
Selbyville, Delaware, Dec. 01, 2019 (GLOBE NEWSWIRE) -- Global Animal Drugs Market is set to cross USD 41 billion by 2025, according to a new research report by Global Market Insights, Inc....
Citius Provides Update on Its CITI Platforms and Gives Investors Further Insight on their Licensing Agreement with MD Anderson Cancer Center
February 06, 2019 13:11 ET
|
The Wall Street Analyzer
NEW YORK, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Citius Pharmaceuticals, Inc.’s (NASDAQ: CTXR) CEO, Myron Holubiak recently caught up with The Wall Street Analyzer to update investors on the companies’...
Cidara Provides Corporate Update and Reports Third Quarter 2018 Financial Results
November 08, 2018 17:23 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
Animal Healthcare Market will achieve 4% CAGR to cross $36 billion by 2024: Global Market Insights, Inc.
September 26, 2018 04:00 ET
|
Global Market Insights, Inc
Sellbyville, Delaware, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Global Animal Healthcare Market is expected to surpass USD 36 billion by 2024, as per a new research report by Global Market Insights,...
Cidara Provides Corporate Update and Reports First Quarter 2018 Financial Results
May 10, 2018 16:05 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results
February 27, 2018 16:32 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
Cidara Provides Corporate Update and Reports Third Quarter 2017 Financial Results
November 08, 2017 16:01 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
Cidara Therapeutics to Report Third Quarter 2017 Financial Results and Provide Corporate Update
November 01, 2017 16:05 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it will...
Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
October 19, 2017 09:00 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the pricing...